Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6EWR

Putative sugar aminotransferase Spr1654 from Streptococcus pneumoniae, PMP-form

Summary for 6EWR
Entry DOI10.2210/pdb6ewr/pdb
DescriptorPutative capsular polysaccharide biosynthesis protein, 4'-DEOXY-4'-AMINOPYRIDOXAL-5'-PHOSPHATE (3 entities in total)
Functional Keywordsteichoic acid, pneumococcus, sugar aminotransferase, pmp, sugar binding protein
Biological sourceStreptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4)
Total number of polymer chains4
Total formula weight192274.18
Authors
Achour, A.,Sun, R.,Sandalova, T.,Han, X. (deposition date: 2017-11-06, release date: 2018-05-02, Last modification date: 2024-01-17)
Primary citationHan, X.,Sun, R.,Sandalova, T.,Achour, A.
Structural and functional studies of Spr1654: an essential aminotransferase in teichoic acid biosynthesis inStreptococcus pneumoniae.
Open Biol, 8:-, 2018
Cited by
PubMed Abstract: Spr1654 from plays a key role in the production of unusual sugars, presumably functioning as a pyridoxal-5'-phosphate (PLP)-dependent aminotransferase. Spr1654 was predicted to catalyse the transferring of amino group to form the amino sugar 2-acetamido-4-amino-2, 4, 6-trideoxygalactose moiety (AATGal), representing a crucial step in biosynthesis of teichoic acids in We have determined the crystal structures of the apo-, PLP- and PMP-bound forms of Spr1654. Spr1654 forms a homodimer, in which each monomer contains one active site. Using spectrophotometry and based on absorbance profiles of PLP- and PMP-formed enzymes, our results indicate that l-glutamate is most likely the preferred amino donor. Structural superposition of the crystal structures of Spr1654 on previously determined structures of other sugar aminotransferases in complex with glutamate and/or UDP-activated sugar allowed us to identify key Spr1654 residues for ligand binding and catalysis. The crystal structures of Spr1654 and in complex with PLP and PMP can direct the future rational design of novel therapeutic compounds against .
PubMed: 29669826
DOI: 10.1098/rsob.170248
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.4 Å)
Structure validation

227561

PDB entries from 2024-11-20

PDB statisticsPDBj update infoContact PDBjnumon